About Index Trending news
Lists
Pricing
OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH

OMEICOS Therapeutics is a biopharmaceutical company developing firstinclass small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation..

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Grant
€1,700,000
Employees

Team size

10+
Locations
HQ
Headquarters
€1,700,000 Grant
businesswire

OMEICOS Secures Continued BMBF Support with New €1.7M Research Grant to Advance its Novel Approach to Treat Cardiovascular Diseases